Vol. 30 (2) 2023
Clinical significance of FOXP3 mRNA expression in patients with B chronic lymphocytic leukemia: A preliminary study The Egyptian Journal of Immunology Volume 30 (2), April, 2023 Pages: 131 – 140. www.Ejimmunology.org https://doi.org/10.55133/eji.300212 Nermine...
Vol. 30 (2) 2023
Associations between IL-17A G/A-rs2275913 and IL 23R A/G-rs11209026 gene polymorphisms and severe coronavirus disease 2019 (COVID-19) The Egyptian Journal of Immunology Volume 30 (2), April, 2023 Pages: 119 – 130. www.Ejimmunology.org...
Vol. 30 (2) 2023
Effect of 17-Hydroxyprogesterone Caproate on Interleukin-6 and Tumor necrosis factor-alpha in expectantly managed early-onset preeclampsia The Egyptian Journal of Immunology Volume 30 (2), April, 2023 Pages: 109 – 118. www.Ejimmunology.org...
Vol. 30 (2) 2023
Markers of inflammasome activation in Coronavirus disease 2019 (COVID-19) Egyptian patients: Impact on disease severity The Egyptian Journal of Immunology Volume 30 (2), April, 2023 Pages: 99 – 108. www.Ejimmunology.org https://doi.org/10.55133/eji.300209 Salma K. Abd...
Vol. 30 (2) 2023
Serum metabolomic profiles and semaphorin-3A as biomarkers of diabetic retinopathy progression The Egyptian Journal of Immunology Volume 30 (2), April, 2023 Pages: 83 – 98. www.Ejimmunology.org https://doi.org/10.55133/eji.300208 Entsar R. Mokhtar1, Doaa A. Mahmoud2,...
Vol. 30 (2) 2023
Galectin-1 in Psoriatic arthritis, Psoriasis, Rheumatoid arthritis and its relation with disease activity and skin lesion The Egyptian Journal of Immunology Volume 30 (2), April, 2023 Pages: 73 – 82. www.Ejimmunology.org https://doi.org/10.55133/eji.300207 Mona M. El...
